Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIF c-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIF c

Published:2016-02-11 Issue:3 Volume:22 Page:389-396
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Berntorp E.¹,Negrier C.²,Gozzi P.³,Blaas P‐M.³,Lethagen S.³⁴

Affiliation:

1. Departments of Hematology and Coagulation Disorders Lund University Skåne University Hospital Malmö Sweden

2. Hematology Division Hemophilia Comprehensive Care Center Hopital Louis Pradel Université Lyon 1 Bron France

3. Swedish Orphan Biovitrum AB Stockholm Sweden

4. University of Copenhagen Copenhagen Denmark

Funder

Biogen

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hae.12887

Reference31 articles.

1. Definitions in Hemophilia

2. Prophylactic therapy for haemophilia: early experience

3. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B

4. Haemophilia in Sweden VII. Incidence, Treatment and Prophylaxis of Arthropathy and other Musculo-Skeletal Manifestations of Haemophilia A and B

5. Analysis of low frequency bleeding data: the association of joint bleeds according to baseline FVIII activity levels

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A;European Journal of Haematology;2023-10-24

2. Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults;Research and Practice in Thrombosis and Haemostasis;2023-08

3. A French Real-World Evidence Study Evaluating the Efficacy, Safety, and Pharmacokinetic Parameters of rVIII-SingleChain in Patients with Hemophilia A Receiving Prophylaxis;Thrombosis and Haemostasis;2023-02-09

4. Efficacy of emicizumab is maintained throughout dosing intervals for bleed prophylaxis;Research and Practice in Thrombosis and Haemostasis;2023-02

5. Area under the curve: Comparing the value of factor VIII replacement therapies in haemophilia A;Haemophilia;2022-11-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3